Diabetes is the leading cause of chronic kidney disease (CKD) and end-stage kidney
disease in the world. It is known that maintaining optimal glycemic control can slow the …

Inpatient diabetes management of those on hemodialysis poses a major challenge. In a post
hoc analysis of a randomized controlled clinical trial, we compared the efficacy of fully …

The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Before the discovery of insulin and diet restriction, the Joslin Clinic reported very high
mortality rates for type 1 diabetes (T1D) that ranged from 824 per 1000 individuals aged 10 …

Background: Automated insulin delivery (AID) systems offer promise in improving glycemic
outcomes for individuals with type 1 diabetes. However, data on those who struggle with …

A technological solution for the management of diabetes in people who require intensive
insulin therapy has been sought for decades. The last 10 years have seen substantial …

As all people with type 1 diabetes (T1D) and some with type 2 diabetes (T2D) require
insulin, there is a need to develop management methods that not only achieve glycemic …

Abstract Objective Approximately 6.3% of the worldwide population has type 2 diabetes
mellitus (T2DM), and the number of people requiring insulin is increasing. Automated insulin …

Controlling blood glucose levels within acceptable limits is crucial to the long-term health of
patients with type 2 diabetes, and patient involvement is a vital element in achieving this …

Combining technologies including rapid insulin analogs, insulin pumps, continuous glucose
monitors, and control algorithms has allowed for the creation of automated insulin delivery …